EP2464382
Samsett meðferð með affukóseruðu CD20 mótefni og bendamústíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.8.2010EP published:
3.5.2017EP application number:
10747168.2
EP translation filed:
21.6.2017Grant published:
15.7.2017EPO information:
European Patent Register
Max expiry date:
11.8.2030Expiry date:
11.8.2026Next due date:
31.8.2026
Title:
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE
Timeline
Today
12.8.2010EP application
3.5.2017EP Publication
21.6.2017Translation submitted
15.7.2017Registration published
11.8.2026Expires
Owner
Name:
Roche Glycart AGAddress:
Wagistrasse 18, 8952, Schlieren-Zuerich, CH
Inventor
Name:
HERTING, FrankAddress:
Penzberg, DE
Name:
KLEIN, ChristianAddress:
Bonstetten, CH
Agent
Name:
Guðjón Styrkársson, hrl.Address:
Njálsgötu 110, 105, Reykjavík,
Priority
Number:
09010489Date:
14.8.2009Country:
EP
Supplementary protection
SPC number:
SPC208
Classification
Categories:
A61K 39/395, C07K 16/28, A61K 31/4184, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 14.7.2017
Expires: 11.8.2018
Payer: Örn Þór, slf.
Number: 9
Paid: 17.7.2018
Expires: 11.8.2019
Payer: Örn Þór, slf.
Number: 10
Paid: 15.7.2019
Expires: 11.8.2020
Payer: Örn Þór, slf.
Number: 11
Paid: 10.7.2020
Expires: 11.8.2021
Payer: Örn Þór slf.
Number: 12
Paid: 13.7.2021
Expires: 11.8.2022
Payer: Örn Þór slf.
Number: 13
Paid: 12.7.2022
Expires: 11.8.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.7.2023
Expires: 11.8.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 23.7.2024
Expires: 11.8.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.8.2025
Expires: 11.8.2026
Payer: Árnason Faktor ehf.